Brock Andersen, MD
Dermatology · Fruitland, IDNPI 1558349852
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,415 of the $1,657 with a category attached, or 85.4%. 16 manufacturers reported payments, led by AbbVie at 31.4% of the total. Reporting peaked in 2019 at $350 and has fallen 53.1% since, to $164 in 2025. That places this record below the midpoint for dermatology clinicians in ID, where the typical reported total is $2,238.
Across 90 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$521
- Johnson & Johnson$414
- Novartis$165
- LEO Pharma Inc.$80
- Boehringer Ingelheim$78
- UCB, Inc.$72
- plus $327 from 10 others
Across 25 payments — averaging $2611.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- LEO Pharma AS$65K
What the payments were for
- Food & beverage$1,41585%
- Education$24215%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $521 |
| Johnson & Johnson | 19 | $414 |
| Novartis | 8 | $165 |
| LEO Pharma Inc. | 4 | $80 |
| Boehringer Ingelheim | 3 | $78 |
| UCB, Inc. | 4 | $72 |
| Amgen | 3 | $63 |
| Sun Pharmaceutical Industries Inc. | 4 | $59 |
| Galderma Laboratories, L.p. | 3 | $52 |
| Lilly USA, LLC | 2 | $45 |
| Genentech USA, Inc. | 2 | $34 |
| Sanofi | 1 | $19 |
| Incyte Corporation | 1 | $17 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Organon | 1 | $7 |
How this compares
$1,657 in reported general payments places this provider in the 40th percentile of 52 dermatology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 14 | $325,739 |
| Humira(Cf) PenAdalimumab | 37 | $305,257 |
| RinvoqUpadacitinib | 18 | $121,704 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 14 | $106,837 |
| OlumiantBaricitinib | 14 | $78,333 |
| Dupixent PenDupilumab | 14 | $54,305 |
| Tacrolimus | 28 | $3,773 |
| Mycophenolate Mofetil | 39 | $3,219 |
| Halobetasol Propionate | 37 | $2,384 |
| Betamethasone Dipropionate | 48 | $2,119 |
| ValacyclovirValacyclovir Hcl | 60 | $2,109 |
| Minocycline Hcl | 150 | $1,975 |
| Clindamycin Phosphate | 33 | $1,709 |
| Clobetasol Propionate | 28 | $1,544 |
| Doxycycline Hyclate | 48 | $1,144 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $521 | $121,70418 claims |
| Lilly USA, LLCOlumiant | $45 | $78,33314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 52 dermatology providers in Idaho.
Other dermatology in Fruitland
- Carl ThornfeldtFruitland$2K
- Alan OlmsteadTwin Falls$405K
- Dustin PortelaBoise$164K
- Steven MingsBoise$82K
- Ryan HarrisMeridian$58K
- Jeffrey DraluckNorthbrook$36K
- Mark SchwendimanMeridian$9K
- Ryan OwsleyNampa$9K
- Kelsey FerrellMeridian$6K
- Nicholas BlickenstaffBoise$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.